Quantrx Biomedical Quick Ratio (QTXB) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Quantrx Biomedical Corporation  (QTXB)

Quantrx Biomedical's Quick Ratio

QTXB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 272 other companies have achieved higher Quick Ratio than Quantrx Biomedical in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 5288 to 6102.

Explain Quick Ratio?
How much Cash & cash equivalents QTXB´s has?
What are QTXB´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QTXB Quick Ratio (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3
Y / Y Current Liabilities Change 16.15 % 8.39 % 1.23 % 8.61 % 9.35 %
Y / Y Cash & cash equivalent Change -81.55 % -94.07 % -87.79 % -89.27 % -65.64 %
Quick Ratio MRQ 0 0 0 0 0.01
QTXB's Total Ranking # 6102 # 5288 # 5374 # 5068 # 5921
Seq. Current Liabilities Change 9.53 % 2.02 % 2.17 % 1.74 % 2.21 %
Seq. Cash & cash equivalent Change 135.97 % -72.2 % -0.5 % -71.74 % -24.16 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 273
Healthcare Sector # 1300
Overall Market # 6102


Quick Ratio Statistics
High Average Low
0.21 0.06 0
(Dec 31 2017)   (Dec 31 2016)




Financial Statements
Quantrx Biomedical's Current Liabilities $ 3 Millions Visit QTXB's Balance sheet
Quantrx Biomedical's Cash & cash equivalent $ 0 Millions Visit QTXB's Balance sheet
Source of QTXB's Sales Visit QTXB's Sales by Geography


Cumulative Quantrx Biomedical's Quick Ratio

QTXB's Quick Ratio for the trailling 12 Months

QTXB Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 8.55 % 6.76 % 5.03 % 8.89 % 6.76 %
Y / Y Cash & cash equivalent TTM Growth -88.61 % -82.08 % -75.59 % -66.92 % -60.54 %
Quick Ratio TTM 0 0 0.01 0.01 0.02
Total Ranking TTM # # # # #
Seq. Current Liabilities TTM Growth 3.92 % 2.03 % 0.32 % 2.05 % 2.22 %
Seq. Cash & cash equivalent TTM Growth -49.66 % -43.03 % -41.23 % -32.4 % -20.84 %

Quick ratio ranking by company, industry and sector >> Back to QTXB Financial Strength Comparisons >> Go to Compare QTXB Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2022 to $2.81 millions, cumulative Quick Ratio